Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Harvard University
- Northeastern University
- University of British Columbia
- University of Maryland, Baltimore
- University of Michigan
- ARDITI - Agência Regional para o Desenvolvimento da Investigação Tecnologia e Inovação
- Eisbach Bio GmbH
- Indiana University
- Missouri University of Science and Technology
- The Jiang Lab, The Icahn School of Medicine at Mount Sinai
- UNIVERSITY OF MELBOURNE
- University of British Columbia Department of Surgery
- Université de Strasbourg
- 3 more »
- « less
-
Field
-
. About Intellia Intellia Therapeutics is a Cambridge-based biotechnology company focused on developing clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies
-
Therapeutics is a Cambridge-based biotechnology company focused on developing clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies to transform lives of people with
-
aging and aging-associated diseases. We use a combination of models (e.g. C. elegans, mouse, iPSCs) and techniques (e.g. gene editing, nanobody generation, small molecule screens) to identify, assess, and
-
The Jiang Lab, The Icahn School of Medicine at Mount Sinai | New York City, New York | United States | 2 months ago
The Jiang Lab (https://labs.icahn.mssm.edu/jianglab/) at the Icahn School of Medicine at Mount Sinai, New York is seeking a highly motivated postdoctoral fellow with expertise in genome editing and
-
characterize cellular and mouse models of TFE3-driven kidney cancer. - Perform molecular biology, genome editing and protein biochemistry experiments. - Study transcription factor regulation, chromatin
-
project on the detection of reovirus infection. We investigate how viral and host factor affect the exposure and accumulation of viral RNA in the cell and investigate the consequences of aberrant exposure
-
career opportunity You will lead experimental embryology and skin biology projects that manipulate avian and vertebrate developmental programs. You will apply advanced imaging, genome editing and
-
University of British Columbia Department of Surgery | Northern British Columbia Fort Nelson, British Columbia | Canada | 2 months ago
biology and gene engineering approaches Developing in vivo strategies to generate antigen-specific Tregs using targeted delivery technologies, including lipid nanoparticles Discovering novel mechanisms by
-
. Expertise in any of the following fields would be beneficial: mass spectrometry, protein purification, gene editing/cell engineering, structural biology. Additional Qualifications If visa sponsorship is
-
(Mtb) or Salmonella enterica serovar Typhimurium (STm). High-throughput screening assays (fluorescence- and luminescence-based). CRISPR-based gene editing, cell transfection/transduction, and primary